Petros Pharmaceuticals, Inc. Accounts Payable
Petros Pharmaceuticals, Inc. (PTPI) had Accounts Payable of $97.28 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $97.28K.
- 2026-03-31: Accounts Payable, Current $133.30K.
- 2025-12-31: Accounts Payable, Current $83.88K.
- 2025-09-30: Accounts Payable, Current $421.14K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $97.28K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $133.30K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $83.88K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $421.14K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $970.02K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $756.70K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $764.33K 10-K · filed 2026-04-15 | $2.33M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.60M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $791.09K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.14M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.71M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.36M 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $1.78M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.86M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.81M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.08M 10-Q/A · filed 2022-11-15 | |
| 2021-12-31 | $4.56M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |